Kerfua SD, Haydon DT, Wilsden G, Ludi A, et al. Evaluation of commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection. Vaccine 2024;42:126325.
PMID: 39270355